Boehringer Ingelheim’s Facebook game Syrum and Janssen’s ‘excellent thinking’ win praise from our expert panel, who open the Digital Yearbook by casting their eye over 2012’s digital developments and close the publication with a look at what 2013 could hold for the industry.
The last 12 months saw a rapid expansion among health monitoring technologies, many of which offered disruptive innovation.
The gains in that space may well foreshadow advances during 2013 in smart devices that allow people to take control of different aspects of their lives.
Back to 2012 and this year we picked out gamification, social media and mobile technology as the three stand-out trends.
Combing PMLiVE’s Digital Intelligence blog for inspiration there are initiatives featured from Boehringer, Janssen, GlaxoSmithKline, Pfizer and Merck & Co.
Industry-wide generalisations are hard to make, but pharma’s work during 2012 proved it could, sometimes, be at the cutting edge of digital.